ANI
13 Aug 2019, 19:07 GMT+10
Mumbai (Maharashtra) [India], Aug 13 (ANI): Sun Pharmaceutical on Tuesday reported a net profit of Rs 1,387 crore in the April to June quarter of 2019-20, up 31 per cent in the year-on period.
The gross sales were up 16 per cent at Rs 8,259 crore. While India sales were up 8 per cent at Rs 2,314 crore, the US finished dosage sales moved up by 12 per cent to 424 million dollars.
The emerging markets sales were flat at 194 million dollars. Rest of the world sales showed a growth of 56 per cent at 167 million dollars. The company made RD investments of Rs 422 crore (5.1 per cent of sales) compared to Rs 500 crore (7 per cent of sales) in Q1 FY19.
"We have recorded growth across most of the markets for the quarter and our performance is in-line with our full-year guidance," said Managing Director Dilip Shanghvi.
"We have recorded growth across most of the markets for the quarter and our performance is in-line with our full-year guidance. We are consistently focusing on improving our efficiencies and cost structure to ensure reasonable returns for our generics business," he said in a statement.
The recent out-licensing of Tildrakizumab and Cequa for Greater China market and the regulatory filing of Tildrakizumab in Japan reflects the company's global aspirations for the specialty business. Ilumya/Ilumetri is gradually gaining traction in the United States and westernEurope, said Shanghvi.
Sun Pharma is the world's fifth largest speciality generic pharmaceutical company and India's top pharmaceutical company. It has 42 manufacturing facilities across six continents. (ANI)Get a daily dose of Asia Pacific Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Asia Pacific Star.
More InformationWASHINGTON, D.C.: President Donald Trump says the United States could soon reach a trade deal with India. He believes this deal would...
DHARAMSHALA, India: The Dalai Lama is set to address a significant three-day conference of Buddhist leaders this week, coinciding with...
Nearly three months after a devastating earthquake struck Myanmar, the country remains trapped in a deepening crisis, compounded by...
Rio de Janeiro [Brazil], July 6 (ANI): Prime Minister Narendra Modi, during the 17th BRICS Summit on Sunday, asserted that condemning...
New Delhi [India], July 6 (ANI): A grand jungle safari project coming up in the Aravalli Hills is going to redefine Haryana's identity....
Generative artificial intelligence spreads across the Global South, and with it spread Western values, ideals and modes of thinking...
NEW YORK CITY, New York: With just weeks to spare before a potential government default, U.S. lawmakers passed a sweeping tax and spending...
PARIS, France: Fast-fashion giant Shein has been fined 40 million euros by France's antitrust authority over deceptive discount practices...
PALO ALTO/TEL AVIV: The battle for top AI talent has claimed another high-profile casualty—this time at Safe Superintelligence (SSI),...
FRANKLIN, Tennessee: Hundreds of thousands of Nissan and Infiniti vehicles are being recalled across the United States due to a potential...
REDMOND, Washington: Microsoft is the latest tech giant to announce significant job cuts, as the financial strain of building next-generation...
LONDON UK - U.S. stock markets were closed on Friday for Independence Day. Global Forex Markets Wrap Up Friday with Greeback Comeback...